Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
Clinical trial NCT02758665 · COMPLETED
Trial details
- NCT number
- NCT02758665
- Sponsor
- University of Ulm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2022-01-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.